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Abstract
New advanced endosonographic techniques have only been introduced recently and will be demonstrated in this video
sequence using the pancreatic organ as a target. The aim of these new techniques is to provide more information about a
certain lesion in order to differentiate these lesions into benign and malignant. Although deﬁnitive differentiation is still
a matter of histology, these new techniques are able to greatly increase the chance of correct diagnosis. Elastography is a
technique which allows the estimation of the hardness of a lesion. The major problem of the technique is, however, that
a hard structure is not necessarily malignant. Contrast-enhanced high mechanical index color Doppler endosonography
was introduced shortly after the development of the ultrasound contrast enhancer. It provides the endosonographist vital
information about the macrovessel system of the pancreas and can therefore discriminate inﬂammatory from malignant
pancreatic lesions with a high degree of certainty. Contrast-enhanced low mechanical index endosonography is newly
introduced into clinical practice and can display the vascularization of pancreatic microvessels. Because there are some
cancerous lesions with an intact microvessel system, the degree of certainty is not as high as the high mechanical index
version; however, it is still useful for clinical practice. The best results with the method can be achieved by using it for
discrimination of cystic pancreatic lesions because of the excellent resolution of the method.
Both methods can be used for a simultaneous three-dimensional (3D) reconstruction. The 3D reconstruction helps to
mark the outlines of a lesion, and the data can be used to scroll through the lesion after the procedure is ﬁnished. This
article is part of an expert video encyclopedia.
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Video Related to This Article
Materials
• For elastography: Equipment with the option of perform-
ing elastography.
• For contrast-enhanced high mechanical index endoso-
nography:
J Electronic endosonography probe (radial or
longitudinal).
J Ultrasound machine with the option of color Doppler
or power Doppler ultrasound.
J Contrast enhancer: 4.8 ml Sonovue, Bracco, Italy.
• For contrast-enhanced low mechanical index
endosonography:
J Electronic endosonography probe (radial or
longitudinal).
J Ultrasound machine with the option of low mechanical
index endosonography.
J Contrast enhancer: 4.8 ml Sonovue.
• For three-dimensional (3D) reconstruction:
J Special software program for 3D reconstruction
J Materials for contrast-enhanced low mechanical index
or high mechanical index endosonography.
• Technique used in the videoclips:
J HI-Preirus Ultrasound machine; Hitachi Medical Cor-
poration, Tokyo, Japan.
J Pentax endoscopic ultrasound (EUS) probe: EG 3870
UTK; Hoya Pentax Corporation, Tokyo, Japan.
Background and Endoscopic Procedures
Elastography is easy to apply when endosonography is per-
formed. The technique allows the measurement of the hard-
ness of a structure in relation to the surrounding tissue.1
Therefore, it is essential to include the surrounding tissue in
the elastographic window. Because of the lack of active pres-
sure application at the end of the endosonography probe,
elastography is so constructed that the information mostly
from the aortic pulse wave is used. This explains the occa-
sional lack of elastographic information. In this case, the
sensitivity of the elastography software has to be increased,
which increases the chance of false readings.
The main problem with elastography arises from the fact that
not all malignant tissue is hard and not all benign tissue is
smooth. Therefore, the tissue surrounding a lesion has to be
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taken into account to get viable results. For discrimination of
pancreatic lesions, in the authors’ study, elastography showed a
sensitivity of 94.7% but a very low speciﬁcity of 33.4% and
therefore cannot be recommended in daily practice.2,3 It has to
be mentioned that with the help of a neuronal network com-
puterization of the elastographic data there could be an im-
provement of the method; however, this is to date not broadly
available.4
For discrimination of pancreatic solid lesions, contrast-en-
hanced high mechanical index endosonography seems to be
the most reliable method to date. The method is able to display
in a unique way pancreatic macrovessels (vessels with a diam-
eter from approximately 0.2 mm and higher) and allows vessel
analysis by using pulse wave Doppler. With this method,
arterial and venous vessel can be discriminated and the neo-
vascularization of the lesions can be revealed. The fact that
malignant lesions only show arterial vessels and inﬂammatory
lesions show venous and arterial vessels side by side can dis-
criminate those lesions in over 90% of cases.5,6 In addition,
malignant arterial vessels show a higher resistance index than
arterial vessels from an inﬂammatory neovascularization, and
this fact can be used additionally to increase the certainty of the
method.7 The lack of visible venous vessels in a pancreatic
carcinoma, using the method, might be because of the invasive
behavior and higher tissue pressure of the lesions.
Recently, contrast-enhanced low mechanical index endoso-
nography has been developed.8–10 The major advantage of the
new method in comparison to the established method is the
higher resolution and visibility of the contrast enhancer bub-
bles. Whereas the high mechanical index Doppler method leads
to the destruction of the microbubbles and therefore can only
be used as a Doppler enhancing method, the more modern
method can show the microvessels of the pancreas as well down
to a bubble size of 3 mm. Unfortunately, the enrichment of the
contrast enhancer in those microvessels is not as speciﬁc as the
discrimination of the different macrovessels systems, as de-
scribed above. However, the method can be used to estimate
contrast-enhancing effects in pancreatic cystic walls. It is pro-
posed that this method has to date the highest possible reso-
lution and so can be effectively used to discriminate
pseudocysts with no contrast-enhancing effects in the cystic wall
from cystic tumors. However, reliable studies are still to come.
Every display method can be combined with a 3D re-
construction method. It has to be mentioned that to date,
endosonography 3D data acquisition is relative, meaning that
no volume studies can be done and the size of the lesion has
to be put in manually in the post-processing process. There-
fore, 3D reconstructions so far can only be used to display the
two-dimensional pictures differently and more impressively,
but cannot add any scientiﬁc value.11 However, using the post-
processing opportunities sometimes reveals more information
because of the lack of stress for the investigator after the real-
time endosonography.
Key Learning Points/Tips and Tricks
• Elastography can distinguish between hard and smooth
tissue.
• Elastography is an additional tool in EUS for the charac-
terization of different lesions but has a limited speciﬁcity in
the differentiation between stiff inﬂammatory changes and
malignant tumor tissue.
• Elastography might be helpful to ﬁnd stiff metastases.
• Contrast-enhanced high mechanical index endosono-
graphy can display different neovascularization patterns of
solid pancreatic lesions.
• Those different neovascularization patterns can distinguish
malignant from benign pancreatic lesions with a high
certainty.
• The estimation of arterial resistant index in contrast-en-
hanced macrovessels can give an additional information.
• Contrast-enhanced high and low mechanical index endo-
sonography complement one another in the differentiation
of solid pancreatic lesions.
• Contrast-enhanced low mechanical index endosonography
is less efﬁcient than high mechanical index endosono-
graphy in differentiation of chronic pancreatitis and pan-
creatic carcinoma.
• Contrast-enhanced low mechanical index endosonography
has excellent resolution and is therefore the ideal method
to estimate pancreatic cystic wall vascularization as a sign
of a cystic tumor.
• 3D reconstruction of endosonographic images provides
new insight into the shape of different lesions and has the
opportunity for post-processing usage; however, it does not
to date provide the opportunity of volume measurement.
Complications and Risk Factors
• Elastography and 3D reconstruction of endosonographic
images do not provide any additional risk in the per-
formance of endosonography.
• Contrast-enhanced methods involve the risk of side effects
of the contrast enhancer in use. Sonovues (Bracco) has
only a few possible side effects. It should not be used in
patients with severe heart diseases and pulmonary failure.
The main risk is an acute allergic reaction, which occurs
very seldom and can normally be treated with antiallergic
medications. Doctors should explain the risks to the pa-
tients beforehand and get a signed letter of agreement.
Blood pressure and pulse monitoring should be performed
during the investigation and half an hour after intravenous
application of Sonovue.12,13
Scripted Voiceover
Time (min:sec) Voiceover text
00:00 The following video sequences show ﬁve modern
endosonographic techniques in a patient with
focal chronic pancreatitis of the pancreatic head.
You will ﬁrst see the elastography mode, then
contrast enhanced high mechanical index
color Doppler ultrasound with 3D
reconstructions and then contrast enhanced
low mechanical index endosonography with 3D
reconstructions.
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00:00–00:08 The ﬁrst video shows an echopoor mass in the
pancreatic head with a blue coding in
elastography. Blue coding is related to a hard
structure of the lesion and leads to a suspicion
of pancreatic cancer in this area.
00:09–1:04 In the following frame we use color Doppler
Endosonography in a very low velocity rate of
5 cm s1, which revealed only a few vessels
within the lesion. After injection of 4.8 mL
contrast enhancer SonovueR, a remarkable
increase of vessel signals can be seen. The use
of pulsed-wave Doppler for vessel analysis
reveals arterial and venous vessels within the
lesion indicating chronic pancreatitis and not
pancreatic cancer. Please note that the diastolic
ﬂow of the arterial spectrum is visible indicating
a low resistance index of the macrovessels.
1:05–1:11 The process of 3D acquisition of the area is shown
in the end of the frame displayed with 4 extra
brackets.
01:12–01:25 The resulting 3D data ﬁle can be reconstructed
and the area of interest can be made visible in a
rotating frame. Please note the dense vessel
structure in the inﬂamed pancreas visualized by
contrast enhanced high mechanical index color
Doppler endosonography.
01:26–01:50 The following frame shows the same area of the
pancreatic head now using the contrast
enhanced low mechanical endosonography
mode. The inﬂux of the microbubbles from the
contrast enhancer can be seen in the
macrovessels of the pancreas as well as in the
microvessels. No lack of enhancement of the
contrast enhancer can be shown indicating
again the benign origin of the lesion. A 3D
reconstruction of the area at the peak of
contrast enhancer inﬂow was made according to
the technique described before.
01:51 – end The resulting rotating image does not show any
areas with lack of the contrast enhancing effect
that clearly displays the benign pancreatic
structure.
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